Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 9(2): e89402, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24586752

RESUMO

Ceramide is important for water retention and permeability barrier functions in the stratum corneum, and plays a key role in the pathogenesis of atopic dermatitis (AD). A Pseudomonas aeruginosa-derived neutral ceramidase (PaCDase) isolated from a patient with AD was shown to effectively degrade ceramide in the presence of Staphylococcus aureus-derived lipids or neutral detergents. However, the effect of ceramide metabolites on the functions of differentiating keratinocytes is poorly understood. We found that the ceramide metabolite sphingosine-1-phosphate (S1P) stimulated the production of inflammatory mediators such as TNF-α and IL-8 from three-dimensionally cultured human primary keratinocytes (termed "3D keratinocytes"), which form a stratum corneum. PaCDase alone did not affect TNF-α gene expression in 3D keratinocytes. In the presence of the detergent Triton X-100, which damages stratum corneum structure, PaCDase, but not heat-inactivated PaCDase or PaCDase-inactive mutant, induced the production of TNF-α, endothelin-1, and IL-8, indicating that this production was dependent on ceramidase activity. Among various ceramide metabolites, sphingosine and S1P enhanced the gene expression of TNF-α, endothelin-1, and IL-8. The PaCDase-enhanced expression of these genes was inhibited by a sphingosine kinase inhibitor and by an S1P receptor antagonist VPC 23019. The TNF-α-binding antibody infliximab suppressed the PaCDase-induced upregulation of IL-8, but not TNF-α, mRNA. PaCDase induced NF-κB p65 phosphorylation. The NF-κB inhibitor curcumin significantly inhibited PaCDase-induced expression of IL-8 and endothelin-1. VPC 23019 and infliximab inhibited PaCDase-induced NF-κB p65 phosphorylation and reduction in the protein level of the NF-κB inhibitor IκBα. Collectively, these findings suggest that (i) 3D keratinocytes produce S1P from sphingosine, which is produced through the hydrolysis of ceramide by PaCDase, (ii) S1P induces the production of TNF-α via S1P receptors, and (iii) released TNF-α stimulates the production of inflammatory mediators such as IL-8.


Assuntos
Mediadores da Inflamação/metabolismo , Queratinócitos/metabolismo , Lisofosfolipídeos/metabolismo , Ceramidase Neutra/metabolismo , Pseudomonas/metabolismo , Esfingosina/análogos & derivados , Células Cultivadas , Endotelina-1/metabolismo , Humanos , Proteínas I-kappa B/metabolismo , Interleucina-8/metabolismo , Inibidor de NF-kappaB alfa , Fosfotransferases (Aceptor do Grupo Álcool)/metabolismo , Receptores de Lisoesfingolipídeo/metabolismo , Esfingosina/metabolismo , Fator de Transcrição RelA/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
2.
Toxins (Basel) ; 4(5): 323-38, 2012 05.
Artigo em Inglês | MEDLINE | ID: mdl-22778903

RESUMO

A divalent cation-independent lectin-HOL-18, with cytotoxic activity against leukemia cells, was purified from a demosponge, Halichondria okadai. HOL-18 is a 72 kDa tetrameric lectin that consists of four non-covalently bonded 18 kDa subunits. Hemagglutination activity of the lectin was strongly inhibited by chitotriose (GlcNAcß1-4GlcNAcß1-4GlcNAc), fetuin and mucins from porcine stomach and bovine submaxillary gland. Lectin activity was stable at pH 4-12 and temperatures lower than 60 °C. Frontal affinity chromatography with 16 types of pyridylaminated oligosaccharides indicated that the lectin had an affinity for N-linked complex-type and sphingolipid-type oligosaccharides with N-acetylated hexosamines and neuramic acid at the non-reducing termini. The lectin killed Jurkat leukemia T cells and K562 erythroleukemia cells in a dose- and carbohydrate-dependent manner.


Assuntos
Citotoxinas/farmacologia , Lectinas/farmacologia , Polissacarídeos/metabolismo , Animais , Sobrevivência Celular/efeitos dos fármacos , Citotoxinas/metabolismo , Testes de Hemaglutinação , Humanos , Células Jurkat , Células K562 , Lectinas/isolamento & purificação , Lectinas/metabolismo , Poríferos
3.
Inflamm Res ; 61(1): 69-78, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22005928

RESUMO

OBJECTIVE AND DESIGN: To investigate whether di-(2-ethylhexyl) phthalate (DEHP) affects the production of inflammatory cytokines by human macrophages. MATERIALS AND METHODS: Differentiated macrophage-like THP-1 cells were exposed to 200 µM DEHP for 3 h, followed by incubation in the presence or absence of opsonized zymosan A, and the concentrations of TNF-α, IL-1ß, IL-8, and IL-6 in the culture media were determined by ELISA. DNA microarray and quantitative real-time RT-PCR analyses were performed to identify genes that showed changes in expression in response to DEHP. RESULTS: DEHP treatment increased the concentrations of TNF-α, IL-1ß, IL-8, and IL-6 in the media, regardless of whether the cells phagocytosed zymosan. DNA microarray analysis showed that DEHP increased the levels of expression of IL-8, CXCL1, CXCL2, CXCL3, CXCL6, CCL3, MMP3, MMP10, MMP14, and CSF2 mRNA, and real-time RT-PCR showed that DEHP significantly enhanced the levels of expression of IL-8, CXCL1, CXCL2, CXCL3, CXCL6, CCL3, MMP10, CSF2, TNF-α, IL-1ß, and IL-6 mRNA in THP-1 cells. DEHP significantly induced translocation of p65 NF-κB into the nucleus. CONCLUSION: DEHP enhances the production of inflammatory cytokines and chemokines by macrophages, and exacerbates their inflammatory response.


Assuntos
Inflamação/tratamento farmacológico , Macrófagos/metabolismo , Ácidos Ftálicos/farmacologia , Adesão Celular , Quimiocinas/metabolismo , Meios de Cultura , Citocinas/metabolismo , Humanos , Hipersensibilidade , Macrófagos/citologia , NF-kappa B/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Reação em Cadeia da Polimerase em Tempo Real/métodos , Transcrição Gênica , Zimosan/farmacologia
4.
Atherosclerosis ; 215(1): 60-9, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21215400

RESUMO

OBJECTIVE: Lipid rafts are cholesterol-enriched microdomains on cell membranes. We hypothesized that these microdomains could involve modified low-density lipoprotein (LDL) uptake. METHODS AND RESULTS: Co-localizations of cholesterol-enriched microdomains and CD204 during the uptake of acetyl LDL (AcLDL) and oxidized LDL were observed using Alexa488-labeled polyethylene glycol cholesteryl ester, which is a sensitive probe used to analyze the dynamics of cholesterol-rich lipid microdomains in living cells. The lipid raft disruptors, methyl-ß cyclodextrin and filipin, inhibited the uptake of AcLDL. CD204 siRNA treatments significantly reduced AcLDL uptake by 80%. We also demonstrated the presence of CD204 in the detergent-resistant membrane fraction (DRM) by immunoblotting analysis. The ratio of CD204/flotillin-1 in DRM was increased 11.5-fold by modified LDL administration. The PI3 kinase inhibitor LY294002, but not the Src kinase inhibitor PP1 or the Gαi/o inhibitor pertussis toxin, inhibited modified LDL uptake. The production of interleukin (IL)-8, but not CCL2, CXCL2, CXCL3, IL-6 or tumor necrosis factor-α was increased by AcLDL administration. The AcLDL-induced IL-8 production was inhibited by LY294002 and filipin. CONCLUSIONS: These data firstly demonstrated that PI3 kinase-associated cholesterol-enriched microdomains are involved in CD204-mediated modified LDL uptake in human macrophages. Cholesterol-enriched microdomains may play a critical role in inflammatory processes.


Assuntos
Macrófagos/metabolismo , Microdomínios da Membrana/metabolismo , Receptores Depuradores Classe A/metabolismo , Adulto , Células Cultivadas , Filipina/farmacologia , Humanos , Lipoproteínas LDL/metabolismo , Masculino , Microdomínios da Membrana/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/fisiologia , Receptores Depuradores Classe A/fisiologia , Transdução de Sinais/efeitos dos fármacos , beta-Ciclodextrinas/farmacologia
5.
Lipids Health Dis ; 10: 1, 2011 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-21199582

RESUMO

BACKGROUND: Oxidized low-density lipoprotein (oxLDL) uptake by macrophages plays an important role in foam cell formation. It has been suggested the presence of heterogeneous subsets of macrophage, such as M1 and M2, in human atherosclerotic lesions. To evaluate which types of macrophages contribute to atherogenesis, we performed cDNA microarray analysis to determine oxLDL-induced transcriptional alterations of each subset of macrophages. RESULTS: Human monocyte-derived macrophages were polarized toward the M1 or M2 subset, followed by treatment with oxLDL. Then gene expression levels during oxLDL treatment in each subset of macrophages were evaluated by cDNA microarray analysis and quantitative real-time RT-PCR. In terms of high-ranking upregulated genes and functional ontologies, the alterations during oxLDL treatment in M2 macrophages were similar to those in nonpolarized macrophages (M0). Molecular network analysis showed that most of the molecules in the oxLDL-induced highest scoring molecular network of M1 macrophages were directly or indirectly related to transforming growth factor (TGF)-ß1. Hierarchical cluster analysis revealed commonly upregulated genes in all subset of macrophages, some of which contained antioxidant response elements (ARE) in their promoter regions. A cluster of genes that were specifically upregulated in M1 macrophages included those encoding molecules related to nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB) signaling pathway. Quantitative real-time RT-PCR showed that the gene expression of interleukin (IL)-8 after oxLDL treatment in M2 macrophages was markedly lower than those in M0 and M1 cells. HMOX1 gene expression levels were almost the same in all 3 subsets of macrophages even after oxLDL treatment. CONCLUSIONS: The present study demonstrated transcriptional alterations in polarized macrophages during oxLDL treatment. The data suggested that oxLDL uptake may affect TGF-ß1- and NF-κB-mediated functions of M1 macrophages, but not those of M0 or M2 macrophages. It is likely that M1 macrophages characteristically respond to oxLDL.


Assuntos
Diferenciação Celular , Lipoproteínas LDL/farmacologia , Macrófagos/patologia , Aterosclerose/etiologia , Aterosclerose/patologia , Biomarcadores , Polaridade Celular , Análise por Conglomerados , Células Espumosas/efeitos dos fármacos , Células Espumosas/patologia , Perfilação da Expressão Gênica , Heme Oxigenase-1/biossíntese , Heme Oxigenase-1/genética , Humanos , Interleucina-8/biossíntese , Interleucina-8/genética , Macrófagos/efeitos dos fármacos , Macrófagos/fisiologia , Transcrição Gênica , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA